Here it is 🎙 “Tech and Drugs – Podcast” Episode #8 with 👩🔬📊 Anindita “Ani” SinhaThe theme for today: Building a Data-Driven Pharma Organization Through Analytics & AIIn this episode of Tech and Drugs, I sit down with Anindita “Ani” Sinha, Vice President of Commercial Operations at Shionogi, whose journey from the microbiology lab to leading analytics, marketing, and field teams has shaped her vision for the future of pharma. With a BA in Biochemistry from Columbia and a PhD in Microbiology from Yale, plus nearly 15 years at Celgene, Bayer, Pfizer, and more, Ani shares how she:We cover:✅ How Ani went from academic research to consulting and then built “analytics first” teams in big pharma✅ Why AI is a powerful tool—but only when you “trust, verify, and know your data’s limits”✅ The critical steps to laying a solid data foundation: understanding, prioritizing, and connecting your datasets✅ Democratizing insights with self-service analytics and AI-driven platforms—finding the sweet spot between structure and flexibility✅ Strategies for attracting and retaining top tech-savvy talent in a highly regulated industry✅ What’s next: next-best-action models, predictive analytics, and cultivating an AI-ready workforceWhether you’re a scientist, data enthusiast, or industry leader, this conversation is packed with practical insights to help you harness analytics and AI for smarter decision-making in drug development and commercialization.💬 What data or AI challenges are you facing in life sciences? Share your thoughts in the comments!